Commercial SARS-CoV-2 Targeted, Protease Inhibitor Focused and Protein–Protein Interaction Inhibitor Focused Molecular Libraries for Virtual Screening and Drug Design

Since December 2019, the new SARS-CoV-2-related COVID-19 disease has caused a global pandemic and shut down the public life worldwide. Several proteins have emerged as potential therapeutic targets for drug development, and we sought out to review the commercially available and marketed SARS-CoV-2-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kralj, Sebastjan, Jukič, Marko, Bren, Urban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745317/
https://www.ncbi.nlm.nih.gov/pubmed/35008818
http://dx.doi.org/10.3390/ijms23010393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745317/
https://www.ncbi.nlm.nih.gov/pubmed/35008818
http://dx.doi.org/10.3390/ijms23010393

Ejemplares similares